Company / FCF Margin
Candel Therapeutics, Inc. FCF Margin History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-19242.4%
FY2022
5-year range
-19242.4% / -8437.6%
FY2021-FY2022
Trend
-128.1%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-19242.4% in FY2022.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2022, fcf margin decreased 128.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | - | - |
| FY2022 | -19242.4% | -128.1% |
| FY2021 | -8437.6% | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026